Kajiwara M
No ORCID on file
· 1 paper in corpus
· active 2024
Top journals
Frequent coauthors
- Endo H 1
- Hira D 1
- Ishimura H 1
- Kotani K 1
- Kobayashi T 1
- Katsube Y 1
- Naganawa H 1
- Nakagawa S 1
- Ohta S 1
- Sugimoto M 1
2024
BackgroundAmong the oral antivirals used for treating patients with mild-to-moderate novel coronavirus disease 2019 (COVID-19), nirmatrelvir/ritonavir (NMV/RTV) and ensitrelvir (ESV) are inhibitors of cytochrome P450 (CYP) 3A, and therefore…